24 / 28
Page 49
Notes:
conferenceseries
.com
Volume 9, Issue 9 (Suppl)
J Cancer Sci Ther, an open access journal
ISSN: 1948-5956
World Cancer 2017
October 19-21, 2017
25
th
WORLD CANCER CONFERENCE
October 19-21, 2017 | Rome, Italy
Single incision for early stage breast cancer: Aminimally invasive approach
Monica Rizzo
Emory University School of Medicine, USA
B
reast conserving surgery (BCS) with sentinel lymph node (SLN) biopsy is standard of care for the treatment of early
stage breast cancers. The use of a minimally-invasive single incision has not been rigorously compared to multi-incision
traditional approach. A tertiary surgical oncology database was retrospectively reviewed over two years study period. The single
incision approach used one incision to resect the tumor and the Lymphazurin-tagged axillary SLNs. The multi-incision group
used a breast and a separate axillary incision. Patient satisfaction was collected in the first postoperative visit and documented
as excellent, good and poor. BCS-SLN accounted for 110 patients with median age 63 years, with 64 (58%) cancers occurring
in the upper outer quadrant (UOQ). There were 48 patients in the single incision group. A single incision approach was used
in 41 (64%) of UOQ cancers (p<0.001), with a median of two SLNs. The single-incision approach showed no difference in
percentage of biopsy clip removal or frequency of tumor-free margins and did not prolong operative time. Overall, eight
patients (7.2%) had positive margins; seven underwent to re-excision and no residual disease was found, one patient refused
additional surgery. Patient satisfaction was excellent in all patients treated with a single incision. There were no differences in
complications or reoperations in the two groups. This study demonstrates that the single incision approach for BCS-SLN is safe
and effective. This technique should be considered for upper outer quadrant breast cancers, and has the potential to improve
patient satisfaction and cosmetic results.
Biography
Monica Rizzo is an Associate Professor of Surgery at Emory University School of Medicine. She is Board Certified by the American College of Surgeons. She did
her Surgical Oncology Fellowship at Emory University. She is an academic surgeon and her clinical expertise includes the surgical treatment of breast cancer,
melanoma, and soft tissue sarcoma. As a researcher, she has published more than 50 research articles in peer reviewed journals. She is currently serving at many
international committees. She is the Chair of the Society of Surgical Oncology Disparity Committee.
mrizzo@emory.eduMonica Rizzo, J Cancer Sci Ther 2017, 9:9(Suppl)
DOI: 10.4172/1948-5956-C1-111